HomeStructural heart diseaseValvular Aortic valve

Valvular Aortic valve

View Category

Antithrombotic Anticoagulants

Galileo: Rivaroxaban After TAVR Stopped Due to Early Event Rates

Patients undergoing transcatheter aortic valve replacement (TAVR) randomized to rivaroxaban in the GALILEO trial experienced higher risk...
solaci -
Learn More
Structural heart disease

Immediate Electrocardiography After TAVI, the Simplest Way to Predict Conduction Disorders

Taking into account a simple 12-lead electrocardiography performed immediately after transcatheter aortic valve implantation (TAVI), removing the...
solaci -
Learn More
Structural heart disease

Ambulatory Continuous Monitoring in Patients with Left Bundle Branch Block After TAVI

The incidence of arrhythmic events up to a year after implantation is high and involves almost half...
solaci -
Learn More
Structural heart disease

Predictors of Conduction Disturbances Requiring a Late Permanent Pacemaker

This analysis shows that baseline right bundle branch block and increased PR length after transcatheter aortic valve...
solaci -
Learn More
HIGHLIGHTS

TCT 2018 | Mismatch After TAVR According to the TVT Registry

Prosthesis-patient mismatch (i.e. a difference between the size of the implanted prosthetic valve and the patient body...
solaci -
Learn More
HIGHLIGHTS

TCT 2018 | COAPT: MitraClip in Patients with Secondary Mitral Regurgitation

The prognosis of patients with heart failure and mitral regurgitation secondary to ventricular dysfunction and dilation is...
solaci -
Learn More
HIGHLIGHTS

TCT 2018 | TriValve: Mitraclip for the Tricuspid Valve

The TriValve is a multicenter, international and retrospective study of multiple devices for percutaneous intervention to treat...
solaci -
Learn More
HIGHLIGHTS

TCT 2018 | SOLVE-TAVI: Self-Expandable vs. Balloon-Expandable Valves and General vs. Local Anesthesia in One Study

This prospective, randomized, multicenter study included 447 patients with severe aortic stenosis and intermediate or high surgical...
solaci -
Learn More